购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Carbonic Anhydrase
    (3)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (2)
  • 35日内发货
    (1)
  • 6-8周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "ca vii"的结果
筛选
搜索结果
TargetMol产品目录中 "

ca vii

"的结果
  • 抑制剂&激动剂
    5
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    2
    TargetMol | Recombinant_Protein
  • hCAI/II-IN-6
    T61745694466-00-7
    hCAI II-IN-6 是一种具有选择性和口服活性的human carbonic anhydrase(CA) 抑制剂。hCAI II-IN-6对 hCA I,hCA II,hCA VII 和 hCA XII 有抑制作用,Ki 值分别为 220,4.9,6.5 和 >50000 nM。hCAI II-IN-6 在体内显示抗惊厥活性。hCAI II-IN-6 可以用于研究癫痫。
    • ¥ 243
    In stock
    规格
    数量
  • hCAVII/IX-IN-1
    T2046211300714-76-4
    hCAVII IX-IN-1 (compound 4) 是一种抑制hCAVII IX的抑制剂,其Ki值分别为56.5 nM和38.2 nM,可用于抗癌研究。
    • 待询
    10-14周
    规格
    数量
  • BChE-IN-36
    T200609
    hBChE-IN-4(compound 40)作为一种hCA激活剂和BChE抑制剂,显示出对多种hCA亚型的高效活性,其KA值对应hCA I、hCA II、hCA IV、hCA VB以及hCA VII分别为266、76.9、918、893和98.0 nM。此外,该化合物在抑制eeAChE和eqBChE方面同样表现出色,IC50值分别仅为72.1和4.2 nM。值得注意的是,hBChE-IN-4无显示出细胞毒性,且被认为具有促进认知功能的有效作用。因其在神经退行性疾病和其他神经精神疾病研究中的潜在应用价值,hBChE-IN-4备受关注。
    • 待询
    规格
    数量
  • EBMI-13B
    T2402421202-53-9
    EBMI-13B is a potent and selective isozymes CA-VA and CA-VII activator.
    • ¥ 10600
    6-8周
    规格
    数量
  • Chlorthalidone Impurity G
    T3587616289-13-7
    Chlorthalidone impurity G is a potential impurity found in commercial preparations of chlorthalidone that has moderate antihypertensive effects. Chlorthalidone is a thiazide-like diuretic that inhibits the Na+/Cl- cotransporter in the distal convoluted tubule of the kidney, which prevents reabsorption of sodium and chloride leading to a reduction in plasma volume and cardiac output. It also inhibits carbonic anhydrase (CA), including the isoforms CAVB, VII, IX, XII, and XIII (Kis = 2.8-23 nM) and, to a lesser extent, CAI, CAII, IV, VA, and VI (Kis = 138-1,347 nM), which may mediate its sustained vasodilatory activity. Dietary administration of chlorthalidone (8 mg per animal per day) reduces arterial hypertension and prevents or reduces ventricular hypertrophy induced by deoxycorticosterone acetate (DOCA) in salt-hypertensive rats. Formulations containing chlorthalidone have been used alone or in combination with other antihypertensive agents to lower arterial blood pressure and as adjuvants to address edema caused by cardiac or renal disorders.
    • 待询
    35日内发货
    规格
    数量